logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10238599 B1

PDFFull Text
Date of Patent:
Mar. 26, 2019

Filed:

Sep. 25, 2017

Composition and method for treating congenital cytomegalovirus induced hearing loss

Applicant:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Inventors:

Josef M. Miller, Ann Arbor, MI (US);

Glenn E. Green, Dexter, MI (US);

Barry Sheldon Seifer, Ann Arbor, MI (US);

Albert Park, Salt Lake City, UT (US);

Ali Ahmed Almishaal, Alahsa-Hufof, SA;

Phayvanh Phithaksounthone Sjogren, Salt Lake City, UT (US);

Assignee:

THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Ann Arbor, MI (US);

Attorney:

Howard & Howard Attorneys PLLC

Primary Examiner:

Sahar Javanmard

Int. Cl.
CPC ...
A61K 33/06 (2006.01); A61K 31/355 (2006.01); A61K 31/60 (2006.01); A61K 31/07 (2006.01); A61K 31/375 (2006.01); A61K 31/245 (2006.01); A61K 9/00 (2006.01); A61K 31/015 (2006.01); A61K 45/06 (2006.01); A61K 31/05 (2006.01); A61K 31/341 (2006.01); A61K 31/58 (2006.01); A61K 31/585 (2006.01); A61K 33/00 (2006.01); A61P 27/16 (2006.01); A61P 31/22 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0046 (2013.01); A61K 9/0019 (2013.01); A61K 31/015 (2013.01); A61K 31/05 (2013.01); A61K 31/07 (2013.01); A61K 31/341 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/58 (2013.01); A61K 31/585 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 45/06 (2013.01); A61P 27/16 (2018.01); A61P 31/22 (2018.01); A61K 2300/00 (2013.01);
Abstract

A method of treating congenital cytomegalovirus (cCMV) induced hearing loss includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.

Find Patent Forward Citations

Quick Actions:

Miller, Josef. (2019). Composition and method for treating congenital cytomegalovirus induced hearing loss (U.S. Patent No. 10238599). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10238599

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…